Archives: Speakers

Josué holds MD from the University of Yaoundé 1, Cameroon and worked (1997-2000) as general practitioner in the University Hospital of Yaoundé. He then completed a MSc in molecular biology at the Free University of Brussels (Vrije Universiteit Brussel), followed by a diabetes cell therapy-focused PhD training and Postdoctoral fellowship at the same university. In 2015, Josué joined the Phase 1 field as Clinical Research Physician in a CRO and started a postgraduate training in Pharmaceutical Medicine, before moving two years later to Pfizer Clinical Research Unit in the role of Principal Investigator. In his current role of Clinical Operations Director, Josué supervises the teams of Investigators, Projects Managers and Regulatory Staff. He is responsible for several innovative projects aiming at improving clinical trial participant’s experience and PCRU deliveries while maintaining full compliance to GCP, national and international regulations. This includes being Subject Matter Expert for electronic consent and for Decentralized Clinical Trial modalities.

Martina holds a Master’s in Pharmaceutical Science from Karl-Franzens-University Graz, Austria. Her certifications include Lean Six Sigma Green Belt, St. Gallen Management Institute Business Strategy, and the London Business School programs re. Accelerated Development as well as the Innovation Through Design Thinking.

Over her 25-year career, she’s taken on multifaceted roles at Fresenius Kabi, Roche, and MSD, spanning divisions across Research, Manufacturing, Commercial and Global Support Functions. She developed drug products to market and pioneered a novel single-use auto-injection device platform for sterile dosage forms. Beyond product development, Martina has been leading business process streamlining, strategic development, and organizational integration. Her achievements include establishing the global MSD Innovation and Development Hub in Zurich, founding the global MSD Center of Excellence for Comparator Blinding, innovating an early phase biologics supply chain, amplifying Enterprise Strategy Office projects as a Design Thinking Facilitator and enhancing the Global Market Access forecasting methodology. Currently she is creating innovative solutions for clinical supply operations, clinical sites, and leading digitalization as well as people innovation endeavors; she is leading the MSD Digital Display Labeling (DDL) project as well as co-leading the cross-industry DDL Community of Practice.

Juliane provides strategic support for the development of patient-focused Phase I-IV rare disease trials and is passionate about advancing rare disease clinical research. Juliane innovates study solutions by combining her therapeutic and operational expertise to make clinical studies more accessible to patients and non-traditional investigators.

Dr. Haun is an experienced medical doctor, trained in internal medicine and emergency medicine, with 10+ years of clinical practice. He has a high-quality 10+ years’ work history in the drug development and research industry. Among his previous experiences, he was the head of a global medical affairs department for 4 years, acted as primary medical monitor in 30+ clinical trials, mainly in complex studies in a variety of therapeutic areas including oncology, rare diseases, and advanced therapies (gene, cell, chaperone therapies, etc.). He joined WEP Clinical bringing his expertise in applying knowledge and skills in epidemiology, internal medicine and different medical specialties in drug development, clinical trials, and drug safety. He has successfully implemented several techniques to improve site identification and selection and patient centric solutions to ensure timely enrolment and high retention in challenging patient populations with rare and ultra-rare diseases. He is also experienced in elaborating study plans (medical monitoring, clinical monitoring, safety management etc.) and tools (site reference manual, pharmacy manual, treatment manual etc.).